| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |